Tag Archives: CENX

best stock buys now

December 8, 2017: Here are four stocks trading with heavy volume among 73 equities making new 52-week lows in Friday’s session. On the NYSE advancers led decliners by about 3 to 2 and on the Nasdaq, advancers led decliners by about 8 to 7.

Sprint Corp. (NYSE: S) posted a new 52-week low of $5.42 Friday, down 0.7% after closing at $5.46 on Thursday. The 52-week high is $9.65. Volume was about 14.5 million, nearly 15% below the daily average of around 16.9 million shares. The company is expected to raise prices as competition cools. Investors aren’t sure they agree.

American Outdoor Brands Corp. (NASDAQ: AOBC) dropped about 16.5% Friday to post a new 52-week low of $12.46 after closing at $14.93 on Thursday. The 52-week high is $24.49. Volume was around 11.5 million, nearly 6 times the daily average of about 1.7 million. The maker of Smith & Wesson firearms beat quarterly estimates but cut its full-year forecasts sharply.

Veeco Instruments Inc. (NASDAQ: VECO) dropped nearly 26% Friday to post a new 52-week low of $10.85 after closing at $14.65 on Thursday. The 52-week high is $34.38. Volume was around 5.8 million, about 10 times the daily average of around 584,000. The company reported late yesterday that it had received an unfavorable patent ruling in China.

best stock buys now: McKesson Corporation(MCK)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    McKesson Corp. (NYSE: MCK), the leading pharmaceutical distributor, posted a revenue increase in the past year of $49.7 billion, up from $47.5 billion in ayear earlier. Its management offered hefty earnings for the quarter and year ahead. It continues to be a buyer of other companies, most recently Change Healthcare (which was labeled a merger with one of McKesson’s divisions). The current dividend is $1.12, or 0.61%.

  • [By Dan Caplinger]

    Drug-distribution specialist McKesson (NYSE:MCK) has had a tough year. Even as the overall stock market has climbed, the company’s shares have suffered, as investors fear that any business related to pharmaceuticals will have a political target on its back even under the current administration. Last quarter’s sluggish numbers didn’t create much enthusiasm for McKesson either.

  • [By ]

    McKesson Corporation (NYSE: MCK) is the largest wholesale distributor of pharmaceuticals, counting CVS and Walmart as major customers. Along with rivals Cardinal Health and AmerisourceBergen, the three control 90% of the $300 billion retail pharmaceutical distribution market.

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 1.77 percent. Meanwhile, top losers in the sector included McKesson Corporation (NYSE: MCK), down 24 percent, and Novo Nordisk A/S (ADR) (NYSE: NVO), down 13 percent.

best stock buys now: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Craig Jones]

    JPMorgan’s analyst Michael Gambardella downgraded Century Aluminum Co (NASDAQ: CENX) from Overweight to Neutral and reduced its price target from $22 to $14.50, citing alumina cost headwinds as the main reason for the downgrade.

best stock buys now: Gaming and Leisure Properties, Inc.(GLPI)

Advisors’ Opinion:

  • [By Seth McNew]

    One way Penn has been able to unlock extra value is by spinning off a portion of operations as a real estate investment trust (REIT) as a way to split up the physical property from the gaming operations. Following that 2013 creation of Gaming and Leisure Properties Inc(NASDAQ:GLPI),Penn essentially pays leasing fees to the REIT so it can focus on operations with a leaner balance sheet. Here’s a more in-depth analysis of the upside of Penn’s REIT model.

  • [By Monica Gerson]

    Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 3.25 percent to $31.90 in pre-market trading. Gaming and Leisure Properties priced offering of 10.53 million shares of common stock for gross proceeds of $333 million.

best stock buys now: Goldfield Corporation (The)(GV)

Advisors’ Opinion:

  • [By Jim Robertson]

    Just before Thanksgiving, our Under the Radar Moversnewsletter suggested buying small cap electrical infrastructure stockGoldfield Corp (NYSEMKT:GV):

best stock buys now: Westell Technologies, Inc.(WSTL)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap high-performance wireless infrastructure solutions stock Westell Technologies (NASDAQ: WSTL) as a buy for our short-term portfolio:

best stock buys now: Apogee Enterprises, Inc.(APOG)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Let me introduce you to Apogee Enterprises (APOG) a company with “yuge” profit potential. Founded in 1949 and headquartered in Minneapolis, Minnesota, APOG designs and develops glass solutions for commercial buildings.

Top 10 Undervalued Stocks To Invest In Right Now

Over the past year, the performance of T. Rowe Price Blue Chip Growth (TRBCX has underscored why it pays to sit tight when a fund with a superior long-term record hits a speed bump. In 2016, as investors turned away from shares of the fast-growing, large-capitalization stocks that Blue Chip targets in favor of more-undervalued fare, the fund lagged the stock market dramatically. Stocks that had previously buoyed the fund, such as Amazon.com and Facebook, were suddenly a drag, says manager Larry Puglia. And energy and utility stockssectors that Blue Chip tends to ignoreperformed exceptionally well.

See Also: Kip 25 Best No-Load Mutual Funds 2017

But these kinds of style shifts dont last forever. Large-cap growth stocks, led by the technology sector, are rebounding this year, and Blue Chip is benefiting. In the first three months of 2017, the fund returned 10.4%, beating Standard & Poors 500-stock index by 4.3 percentage points. Over the past 12 months, Blue Chip, a member of the Kiplinger 25, outpaced the index by nearly a full percentage point. (Prices and returns are through March 31)

Top 10 Undervalued Stocks To Invest In Right Now: L-3 Communications Holdings, Inc.(LLL)

Advisors’ Opinion:

  • [By Paul Ausick]

    Five teams are expected to compete for the contract: Boeing Co. (NYSE: BA) has joined with Saab to offer a clean-sheet design; Northrop Grumman Corp. (NYSE: NOC) has teamed up with BAE Systems and L-3 Communications Holdings Inc. (NYSE: LLL) on another clean-sheet design; Lockheed Martin Corp. (NYSE: LMT) and Korea Aerospace Industries (KAI) are going with a modified KAI T-50; Raytheon Corp. (NYSE: RTN) has joined with Italy’s Leonardo and Canada’s CAE Inc. (NYSE: CAE) on a version of Leonardo’s M-346 trainer that it calls the T-100; and privately held Sierra Nevada has partnered with Turkish Aerospace Industries (TAI) on another clean-sheet design.

  • [By Peter Graham]

    A long term performance chart shows ViaSat, Inc plus mid to large cap communications stockslikeHarris Corporation (NYSE: HRS) and L-3 Communications Holdings, Inc (NYSE: LLL)had been moving in tandem until last yearwhile small cap Gogo Inc has underperformed:

  • [By Peter Graham]

    Headquartered in New York City, large cap L3 Technologies Inc (NYSE: LLL) employs approximately 38,000 people worldwide and is a leading provider of a broad range of communication, electronic and sensor systems used on military, homeland security and commercial platforms. L3 is also a prime contractor in aerospace systems, security and detection systems, and pilot training. The Company reported 2016 sales of $10.5 billion.

Top 10 Undervalued Stocks To Invest In Right Now: Salesforce.com Inc(CRM)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Cloud-software leader Salesforce (CRM) – my Top Pick for 2017 among large cap technology stocks — remains well positioned to reap the benefits of the transition away from on-premises solutions.

  • [By WWW.THESTREET.COM]

    “There are two things that mess up your relationships, it’s anger and fear,” explains Robbins. Robbins points to Salesforce (CRM) CEO Marc Benioff as being a total giver, which has set him up for success in business.

  • [By Peter Graham]

    On the earnings call, Ellison noted that the company had surpassed Salesforce.com, inc (NYSE: CRM) in annualized recurring cloud revenue: We are now well on our way to passing them and becoming number one in the enterprise SaaS market.”

Top 10 Undervalued Stocks To Invest In Right Now: TG Therapeutics, Inc.(TGTX)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Treehouse Foods (THS) , TG Therapeutics (TGTX) , Kinder Morgan (KMI) , Magellan Midstream Partners (MMP) , Chesapeake Energy (CHK) and Arconic (ARNC) .

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday's regular session.

  • [By Brian Orelli]

    TG Therapeutics (NASDAQ:TGTX)rose 15% today, after an analyst at Jefferies initiated coverage with a buy and a $23 price target.

    So what

    Analyst action often has an effect on company’s stock price, especially in the short term, but today’s move may be exacerbated by an upcoming data release at the American Academy of Neurology meeting scheduled for Friday. Investors may have been jumping in today ahead of the binary event, hoping that Friday’s data will be positive enough to send the share price even higher.

Top 10 Undervalued Stocks To Invest In Right Now: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Todd Campbell]

    Tesaro’s (NASDAQ:TSRO)ovarian cancer drug, niraparib, will begin competing for prescriptions earlier than expected. Niraparib, which will be sold under the brand name Zejula, notched FDA approval on Monday, more than three months ahead of its June 30 decision date. The early approval setsTesaro up for a fierce battle for market share withAstraZeneca (NYSE:AZN)and Clovis Oncology (NASDAQ:CLVS), both of which market drugs that work similarly to Zejula.

  • [By Ben Levisohn]

    Shares of Tesaro (TSRO) are soaring today after the biotech company reported positive data for its treatment of ovarian cancer over the weekend. Credit Suisse analyst Alethia Young and team contend that “M&A remains in focus” for Tesaro following the data:

    Getty Images

    We are increasing our target price to $122 from $90 as we move to an M&A DCF valuation. We were at ESMO this weekend, and we believe the big takeaway on Tesaro data is that it works broadly in all 2L ovarian populations and safety looks solid. We also think the robustness of this data bodes well from PRIMA and QUADRA but are maintaining our POS here. We have looked at our model and also adjusted durations in first-line. We think Tesaro remains one of the most attractive and de-risked cancer assets in our landscape and the company has been cited in major press sources as a takeout target (Bloomberg, Investor Business Daily).

    We think M&A remains in focus for Tesaro. Our M&A DCF valuations range from $122 to $157 by our model. We have also built models for other cancers like NSCLC, SCLC, prostate, and others where PARP might be impactful. We assume 0% POS for now but we conservatively see at least another $1B in sales from PARP expansion. Tesaro has been cited in the press as a potential M&A target and is a company we frequently hear mentioned as a target from our conversations. We think the demand for late stage oncology assets is high, especially in the PARP space given the potential for activity across a range of tumors. For a large Pharma player who already has an oncology salesforce and large R&D infrastructure we could see SG&A synergies of 50-75% and R&D synergies of 15-30%. In our base case TSRO P&L we model a tax rate of 30% so there could be synergies here as well. Two additional key swing factors which might be included in a CVR are how much expansion from PARP in other cancers and immuno-oncology…

    Ex M&A,

  • [By Ben Levisohn]

    Look out below! Shares of Tesaro (TSRO) have dropped more than 10% this afternoon after AstraZeneca (AZN) released stronger-than-expected Phase 3 trial data on a its ovarian cancer treatment.

    Agence France-Presse/Getty Images

    The Street’sAdam Feuerstein has the details on AstraZeneca’s strong data and its impact on Tesaro:

    AstraZeneca’s (AZN) PARP inhibitor Lynparza delayed the recurrence of ovarian cancer by more than two years compared to a placebo, according to results from a phase III study presented Tuesday.

    The strong benefit observed with Lynparza as ovarian cancer maintenance therapy exceeded investor expectations and bolsters AstraZeneca against a competing PARP inhibitor from Tesaro (TSRO).

    Feuerstein also notes that AstraZeneca’s data could be good newsClovis Oncology (CLVS), which also had a PARP inhibitor approved recently, if it means that its drug could work as well as Astra’s.

    In February, Leerink cut Tesaro, arguing that the rally in its shares due to a potential takeover had run too far. Will it still be a takeover target?

    Shares of Tesaro have dropped 14% to $148.01 at 3:28 p.m. today, while AstraZeneca has gained 1.1% to $30.41, and Clovis Oncology has jumped 9.8% to$66.55.

    UPDATE:Piper Jaffray’sSteven Breazzano andJoshua Schimmer note that the AstraZeneca data shows that PARPs are “more similar than different.” They explain:

    This afternoon AstraZeneca (covered by PJC analyst Richard Purkiss) reported the detailed results from the SOLO-2 maintenance study of Lynparza in 2L+ ovarian cancer. The detailed data highlights a PFS benefit of 14 months (investigator assessed, and primary endpoint) and 25 months (blinded central review) over placebo, and favorable hazard ratio of 0.30 and 0.25, respectively, confirming our view that the PARP’s are more similar than different. As such, we believe this provides a favorable readth

  • [By Ben Levisohn]

    Guggenheim’s Tony Butler and Kaitlin Sandor argue that Gilead Sciences (GILD) should buy Syndax Pharmaceuticals (SNDX), Corvus Pharmaceuticals (CRVS), and Tesaro (TSRO) to solve its problem of slowing sales:

  • [By George Budwell]

    Unfortunately for Clovis and its shareholders, though, Astra’s Lynparza is currently underpriority review with the FDA as a maintenance therapy in ovarian cancer, andTesaro’s (NASDAQ:TSRO)rival PARP inhibitor Zejula gained an early approval– along with afar broader label than Rubraca — just this week.

  • [By Todd Campbell]

    The PARP battle is on. Following news that AstraZeneca’s (NYSE:AZN) PARP-inhibiting cancer drug Lynparza delivered a big win in phase 3 studies, all eyes now shift to how a potential Food and Drug Administration approval for Lynparza will reshape the commercial opportunity for competitor Tesaro Inc. (NASDAQ:TSRO).

Top 10 Undervalued Stocks To Invest In Right Now: Intercontinental Exchange Inc.(ICE)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Altria (MO) , Intercontinental Exchange (ICE) and Micron Technology (MU) .

    Cramer was bearish on NVIDIA (NVDA) and Reynolds American (RAI) .

Top 10 Undervalued Stocks To Invest In Right Now: Exactech Inc.(EXAC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

Top 10 Undervalued Stocks To Invest In Right Now: Cemex S.A.B. de C.V.(CX)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Cemex SAB de CV (CX) is very interesting at these levels as it seems the market is pricing in a stronger dollar (thereby reducing revenue) and thus lower growth.

  • [By Paul Ausick]

    Cemex SAB de CV (NYSE: CX) dropped about 2.4% Friday to post a new 52-week low of $7.41 after closing at $7.59 on Thursday. The 52-week high is $10.37. Volume was around 8.8 million, about 15% below the daily average of around 9.3 million. The Mexico-based cement company had no specific news.

  • [By Paul Ausick]

    Cemex SAB de CV (NYSE: CX) dropped about 2.7% Thursday to post a new 52-week low of $7.57 after closing at $7.78 on Wednesday. The 52-week high is $10.37. Volume was around 6.8 million, about 15% below the daily average of around 8.3 million. The Mexico-based cement company had no specific news.

  • [By Paul Ausick]

    Cemex SAB de CV (NYSE: CX) dropped about 1.8% Wednesday to post a new 52-week low of $7.16 after closing at $7.29 on Tuesday. The 52-week high is $10.37. Volume was around 7 million, about 20% below the daily average of around 9.5. The Mexico-based cement company had no specific news.

Top 10 Undervalued Stocks To Invest In Right Now: Ultragenyx Pharmaceutical Inc.(RARE)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was indicated down 7% at $72.85 on Thursday due to results from a seizure medication study. It was downgraded to Neutral from Overweight at Piper Jaffray, and Wedbushlowered its target for the stock.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston
  • [By Johanna Bennett]

    Nothing guts a drug stock like bad clinical trial data. Shares of Ultragenyx Pharmaceutical (RARE) fell as much as 10% after a seizure medication failed in a phase II study.

    Trading at a recent $72.22, the shares were down 7.7% after earlier falling as much as 10% to $70.51

    The seizure drug UX007 was tested as a treatment for glucose transporter type-1 deficiency syndromeor Glut1 DSamong a small group of patients. Data released Wednesday showed that it only cut the rate of seizures in the drug arm by 13.4% compared to the placebo arm, falling short of statistical significance.

    Investigators, though, teased out a clinically — though not statistically — significant benefit for patients experiencing what are called absence seizures. Ultragenyx now intends to focus on that in a Phase III pivotal trial.

    Leerik analyst Joseph Schwartz called the selloff a buying opportunity.

    We had been cautious on this asset (and its two programs – G1DS and long-chain fatty acid oxidation disorder/LC-FAOD; LINK) – but believe the selling pressure after mkt. presents a buying opportunity ahead of a more de-risked X-linked hypophosphatemia (XLH) Ph.3 data in 1H17.

    Cowen analyst Eric Schmidt remained convinced of RAREs long-term prospects thanks to a diversified orphan disease pipeline. And analysts at Credit Suisse see more catalysts ahead in 2017.

    We are buyers on a pullback and we like RAREs setup for the remainder of 2017…Remaining 2017 catalysts keep us buyers on a pullback: We see Q2:17 KRN23 ph3 adult XLH data, H1:17 rhGUS FDA/EMA submission, potential KRN23 CHMP decision in mid-17 (based on late-2016 EMA submission/validation), H2:17 Ace-ER ph3 GNEM data, and potential KRN23 FDA submission in late-17/early-18 as upcoming catalysts worth owning for.

Top 10 Undervalued Stocks To Invest In Right Now: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Craig Jones]

    JPMorgan’s analyst Michael Gambardella downgraded Century Aluminum Co (NASDAQ: CENX) from Overweight to Neutral and reduced its price target from $22 to $14.50, citing alumina cost headwinds as the main reason for the downgrade.

Top 10 Undervalued Stocks To Invest In Right Now: Lithium X Energy Corp. (LIXXF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

  • [By Tom Bishop]

    Lithium X Energy NPV (LIXXF) owns 50% of the Sal de los Angeles lithium brine project in the prolific “Lithium Triangle” in mining friendly Salta province, Argentina.

number one stock to buy

8 Things Most Americans Dont Know About Retirement

Comments Flood In on DOL Fiduciary Rule Delay

Betterment Rebuffs Buffett, Says Sages Advice Doesnt Work Anymore

In spite of the severe impact the financial crisis had, a slew of eager, bonus-hungry millennials are now working in the industry in hopes of forging successful careers. How are they doing?

Alas, many are a strung-out, rattled mess, Jonathan Alpert, known as “The Wall Street Therapist,” told ThinkAdvisor in an interview. The practitioner counts several young traders, analysts, bankers and financial advisors among his clients.

Do these Wall Streeters ever seek your services because of adverse effects from, for example, overuse of cocaine?

On occasion. If it’s affecting their relationships or their work performance.

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources STRAIGHT-THROUGH PROCESSING FOR THE FINANCIAL SERVICES INDUSTRY

STP can be described as electronically capturing and processing transactions in one pass, from the point of first ‘deal’ to final settlement.

number one stock to buy: Murphy Oil Corporation(MUR)

Advisors’ Opinion:

  • [By Matt Egan]

    Before Tuesday, Big Oil’s credit ratings had been left largely intact by S&P. But with oil sinking back to $30 a barrel, the ratings firm took action by downgrading Chevron (CVX), EOG Resources (EOG), Apache (APA), Devon Energy (DVN), Hess (HES), Marathon Oil (MRO), Murphy Oil (MUR), Continental Resources (CLR) and Southwestern Energy (SWN).

  • [By Joshua Bondy]

    Murphy Oil (NYSE: MUR  ) has already spun off its US retail operations into Murphy Oil USAandis exploring the possibility of spinning off its U.K. refining operations. Divesting its refineries will help direct excess cash to developing new fields.

  • [By Ben Levisohn]

    It wasn’t just Marathon that got clipped as the eight worst-performing stocks in the S&P 500 came from the energy sector, including Murphy Oil (MUR), which fell 6.7% to $25.87, Devon Energy (DVN), which slid 6.5% to $40.72, and Chesapeake Energy (CHK), which stumbled 6.1% to $4.94. No surprise, then, that the Energy Select Sector SPDR ETF (XLE) slumped 2.6% to $69.65.

  • [By Ben Levisohn]

    Today, it was all about oil afterOPEC “reached an understanding” on capping oil production. And that made Murphy Oil (MUR) the hottest stock in the S&P 500.

number one stock to buy: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Craig Jones]

    JPMorgan’s analyst Michael Gambardella downgraded Century Aluminum Co (NASDAQ: CENX) from Overweight to Neutral and reduced its price target from $22 to $14.50, citing alumina cost headwinds as the main reason for the downgrade.

number one stock to buy: SPDR Dow Jones Industrial Average ETF (DIA)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    A good way to play this is by buying the SPDR Dow Jones Industrial Average ETF (DIA), which tracks the Dow Industrials. We add that the SPDR S&P 500 ETF Trust (SPY) would be a good bet as well.

  • [By Tom Gentile]

    An ETF is a fund that tracks indexes such as the Dow Jones Industrial Average and the S&P 500. ETFs basically let you trade an entire sector instead of having to pick and choose specific stocks to trade within a sector. ETFs are also a great way for you to hedge against rising interest rates. When it comes to equities, a good ETF to monitor is the SPDR Dow Jones Industrial Average ETF (NYSE Arca: DIA). For bonds, the iShares 20+ Year Treasury Bond ETF (NYSE Arca: TLT) is a good way to gauge the bullishness or bearishness of the overall bond market.

  • [By WWW.MONEYSHOW.COM]

    An easy way to profit from this bull market is to buy the ETFs that track these major averages – the SPDR Dow Jones Industrial Average ETF (DIA) and iShares Dow Jones Transportation Average ETF (IYT).

  • [By Elizabeth Balboa]

    Since the beginning of 2017, the NIFTY has outperformed both the SPDR S&P 500 ETF Trust (NYSE: SPY) and SPDR Dow Jones Industrial Average ETF (NYSE: DIA), with each seeing respective increases of 12.6 percent, 6 percent and 4.9 percent.

number one stock to buy: McKesson Corporation(MCK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By Douglas A. McIntyre]

    McKesson Corp. (NYSE: MCK), the leading pharmaceutical distributor, posted a revenue increase in the past year of $49.7 billion, up from $47.5 billion in ayear earlier. Its management offered hefty earnings for the quarter and year ahead. It continues to be a buyer of other companies, most recently Change Healthcare (which was labeled a merger with one of McKesson’s divisions). The current dividend is $1.12, or 0.61%.

  • [By Ben Levisohn]

    Leerink’s David Larsen and Matt Dellelo traces today’s big gain to Amerisource’s big drop following McKesson’s (MCK) earnings last week:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 1.77 percent. Meanwhile, top losers in the sector included McKesson Corporation (NYSE: MCK), down 24 percent, and Novo Nordisk A/S (ADR) (NYSE: NVO), down 13 percent.

  • [By Dan Caplinger]

    Drug-distribution specialist McKesson (NYSE:MCK) has had a tough year. Even as the overall stock market has climbed, the company’s shares have suffered, as investors fear that any business related to pharmaceuticals will have a political target on its back even under the current administration. Last quarter’s sluggish numbers didn’t create much enthusiasm for McKesson either.

number one stock to buy: Rex Energy Corporation(REXX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Our peer group is up an average of 46% over the past 4 weeks in response to a 30% rebound in the 12-month strip NYMEX oil price. Some of the largest gainers include Hold and Sell rated stocks that we would not chase such asDenbury Resources (Sell, +138%), Halcon Resources (HK) (Sell, +147%), Jones Energy (JONE) (Hold, +166%), Rex Energy (REXX) (Sell, +60%), Sanchez Energy (SN) (Hold, +93%), Ultra Petroleum (UPL) (Sell, +61%), andWhiting Petroleum (Hold, +103%), which have outperformed the E&P Index (+32%) over the same time period. Balance sheets and/or well level returns remain challenged for these companies despite improved oil prices. While we believe oil markets should re-balance over the next 12 to 15 months, the recent recovery to $40 could reverse during 2Q16 as bloated inventories continue to rise, new volumes from Iran pressure an oversupplied market, and a highly anticipated decline in non-OPEC supply (especially in the U.S.), is not as steep as expected. The risk of an oil price retracement, which would significantly pressure the recent out-performers, outweighs the upside in these stocks, in our view. However, we are raising our target prices on Buy ratedAnadarko Petroleum ($54 from $48), Concho Resources (CXO) ($120 from $109), Matador Resources (MTDR) ($22 from $21),Noble Energy (NBL) ($40 from $34), SM Energy (SM) ($22 from $15), Rice Energy ($14 from $12), Pioneer Natural Resources (PXD) ($155 from $135),Continental Resources ($32 from $28), and Parsley Energy (PE) ($24 from $23). We believe our Buy-rated stocks are better positioned to weather challenging oil markets.

number one stock to buy: AmTrust Financial Services, Inc.(AFSI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of AmTrust Financial Services Inc (NASDAQ: AFSI) were down around 18 percent to $22.79 after the company posted downbeat Q4 earnings.

    Shutterstock Inc (NYSE: SSTK) was down, falling around 19 percent to $42.04 after the company reported downbeat Q4 results and issued a weak outlook.

  • [By Lisa Levin]

    In trading on Friday, financial shares fell 0.24 percent. Meanwhile, top losers in the sector included AmTrust Financial Services Inc (NASDAQ: AFSI), down 18 percent, and GSV Capital Corp (NASDAQ: GSVC), down 9 percent.

  • [By Dan Caplinger]

    The stock market kept performing well on Monday, and the Dow Jones Industrials posted its 12th straight all-time record high. Market sentiment was sunny following the release of Warren Buffett’s annual shareholder letter over the weekend, and the Oracle of Omaha made positive comments about the sustainability of the current bull market, which was able to overcome early declines in the major market benchmarks. However, some stocks didn’t fare as well as the overall market, and Tesla (NASDAQ:TSLA), AmTrust Financial Services (NASDAQ:AFSI), and Horizon Pharma (NASDAQ:HZNP) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin]

    In trading on Tuesday, financial shares fell 0.32 percent. Meanwhile, top losers in the sector included Oak Valley Bancorp (NASDAQ: OVLY), down 7 percent, and AmTrust Financial Services Inc (NASDAQ: AFSI) down 5 percent.

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Paul Ausick]

    AmTrust Financial Services Inc. (NASDAQ: AFSI) dropped about 28% Tuesday to post a new 52-week low of $13.51 after closing Monday at $18.87. The stock’s 52-week high is $28.48. Volume of about 19 million shares was about 9 times the daily average of around 2.1 million. A whistleblower report has resulted in an SEC probe into the company’s accounting practices.

stock market day trading

Nike (NKE) tumbled to the bottom of the S&P 500 today after it beat earnings but missed on sales.

Getty Images

Nikedropped 7.1% to $53.92–its largest percentage decline since June 2012–despite beating earnings forecasts for a 19th consecutive quarter. The S&P 500 rose 0.2% to 2,348.45.

Baird’s Jonathan Komp and Benjamin Bray recommend being “aggressive short-term buyers” of Nike:

Retaining Outperform rating with new $62 price target. FQ3 EPS topped consensus (SG&A/tax driven), but gross margin disappointed, and North America wholesale challenges remain (futures -9%). Nike is accelerating key “triple-double” initiatives, while also editing SKUs/costs for greater efficiency. These efforts are supporting healthy underlying F2018 expectations (revenue growth in all markets, EPS implied +mid-teens ex-currency), though we are trimming estimates to reflect significant currency impacts. We still would be more aggressive short-term buyers on pullbacks (<$55), or with signs of faster fundamental improvement.

stock market day trading: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Craig Jones]

    JPMorgan’s analyst Michael Gambardella downgraded Century Aluminum Co (NASDAQ: CENX) from Overweight to Neutral and reduced its price target from $22 to $14.50, citing alumina cost headwinds as the main reason for the downgrade.

stock market day trading: White Mountains Insurance Group, Ltd.(WTM)

Advisors’ Opinion:

  • [By Money Morning News Team]

    Most Expensive Stocks No. 6: White Mountains Insurance Group Ltd.
    The sixth most expensive stock you can buy is Bermuda-based White Mountains Insurance Group Ltd. (NYSE: WTM). The insurance company currently trades at $826.04 a share.

  • [By Ashley Moore]

    Here is a table of the 10 most expensive stocks trading on U.S. markets today:

    Company (Ticker)Price per ShareMarket CapBerkshire Hathaway Inc. (NYSE: BRK-A)$ 257,227.52$ 419.50 billionSeaboard Corp. (NYSEMKT: SEB)$ 3,760.00$ 4.48 billionNVR Inc. (NYSE: NVR)$ 1,944.23$ 7.19 billionThe Priceline Group Inc. (Nasdaq: PCLN)$ 1,727.94$ 80.82 billionMarkel Corp. (NYSE: MKL)$ 978.51$ 13.78 billionWhite Mountains Insurance Group Ltd. (NYSE: WTM)$ 935.01$ 4.25 billionAmazon.com Inc. (Nasdaq: AMZN)$ 846.08$ 408.27 billionAlphabet Inc. (Nasdaq: GOOGL)$ 844.06$ 582.85 billionAutoZone Inc. (NYSE: AZO)$ 744.26$ 21.04 billionIntuitive Surgical Inc. (Nasdaq: ISRG)$ 735.63$ 28.41 billion

stock market day trading: Range Resources Corporation(RRC)

Advisors’ Opinion:

  • [By Paul Ausick]

    Range Resources Corp. (NYSE: RRC) is rated Buy with a lowered price target of $43. The 2017 EPS estimate has been lowered from $0.85 to $0.68, and the 2018 estimate waslowered from $1.60 to $1.52. Shares closed at $27.34 on Friday, in a 52-week range of $27.07 to $46.96, and the consensus price target is $46.42. Range Resources is a Jefferies Franchise Pick.

  • [By Paul Ausick]

    Range Resources Corp. (NYSE: RRC) dropped about 12.8% Wednesday to register a new 52-week low of $17.71 after closing at $20.30 on Tuesday. The 52-week high is $43.60. Volume was nearly 20 million, nearly 4 times the daily average. The natural gas producer missed estimates this morning and revised its growth projections downward. It was one of several energy companies that took some price target cuts from analysts.

  • [By Matthew DiLallo]

    According to a report by PLS, producers spent more than $23 billion locking up prime positions in the Permian Basin and another $7 billion on Mid-Continent acreage acquisitions. However, most of those were smaller deals, with the top transaction weighing in at $2.5 billion. Meanwhile, the Ark-La-Tex region near the Gulf Coast quietly tied for the second hottest M&A geography in the country, largely because of Range Resources (NYSE:RRC) acquisition of Memorial Resource Development. Range Resources paid $4.2 billion, which includes the assumption of debt, to gain a leading position in the Lower Cotton Valley region of Northern Louisiana. Not only is the play saturated with natural gas, but it’s also near the Gulf Coast, which is expected to see increased demand from new petrochemical and industrial complexes as well as LNG export facilities. In other words, Range Resources made a big bet on higher gas prices along the Gulf Coast.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Range Resources Corp. (NYSE: RRC) which traded downabout 12% at $17.90. The stocks 52-week range is $17.68 to $43.60. Volume was about 25 million versus the daily average of 5.6 million shares.

  • [By WWW.THESTREET.COM]

    Range Resources (RRC) was upgraded to outperform at BMO. $44 price target The valuation is more attractive, as business fundamentals are improving, BMO said. 

  • [By Ben Levisohn]

    Talk about a Barron’s bounce!Range Resources (RRC) has soared to the top of the S&P 500 today after Barron’s touted it in the pages of the magazine this weekend.

    Agence France-Presse/Getty Images

    Range Resources gained 4.1% to $28.47, while the S&P 500 slipped 0.3% to2,375.31.

    Barron’s Andrew Bary called Range Resources “an unappreciated energy play.” He explains why:

    With major market indexes at record highs, natural-gas stocks are among the few depressed industry groups. Blame a warm winter and weakening gas prices.

    Range Resources (ticker: RRC), a leading U.S. gas producer, looks undervalued. Its shares, at $27, are down 20% this year and are much below their 52-week high of $47, set last June. Range drilled the first well in the now-prolific Marcellus region of Pennsylvania more than a decade ago and amassed one of its largest land positions there610,000 acres. Its $4.2 billion purchase of Memorial Resource Development last September gave it access to what the company views as a prolific and underappreciated gas region: northern Louisiana

    Range Resources’ market capitalization rose to $7 billion today from $6.8 billion on Friday. It reported net income of $521 million on sales of $1.4 billion in 2016.

stock market day trading: American Software, Inc.(AMSWA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of American Software, Inc. (NASDAQ: AMSWA) were down 12 percent to $10.58. American Software reported preliminary Q4 adjusted earnings of $0.09 per share on revenue of $26.3 million.

stock market day trading: Permian Basin Royalty Trust(PBT)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

stock market day trading: Canon, Inc.(CAJ)

Advisors’ Opinion:

  • [By Dan Carroll]

    Nikon’s story is similar to what’s plaguing its Japanese rival, Canon (NYSE: CAJ  ) . Canon’s stock has nosedived by 20% year to date, but the stock’s recovered nearly 3% over the past month. Don’t let appearances fool you: The company slashed its full-year sales and profit forecasts back in July, as the worldwide camera market has slumped, and as smartphones continue to take over this aging niche. Canon’s route back to respectability looks like a treacherous climb.

  • [By Paul R. La Monica]

    Miscellaneous shorts. Lamensdorf is also betting against Japanese printer and camera giant Canon (CAJ) since he believes the company still hasn’t figured out a way to compete with smartphones.

Top 10 Bank Stocks To Watch For 2018

Related MTOR 18 Biggest Mid-Day Gainers For Wednesday 18 Biggest Mid-Day Gainers For Monday
Related WFC Plaid: The Fintech Link Between Banks And Startups Wells Fargo Revisits May Low After Fraudulent Accounts Count Escalates

Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity.

Here's a recap of the options alerts from Friday, September 1, 2017. All time stamps are in Eastern Time.

2:22:35 pm: NQ NQ Mobile Sep 15 $3.5 Calls Sweep (23) at the Ask: 2687 @ $0.27 vs 1952 OI; Ref=$3.47

12:48:28 pm: HIMX Himax Mar 16 $11 Puts Sweep (3) at the Ask: 852 @ $2.05 vs 50 OI; Ref=$10.44

12:29:21 pm: SEE Sealed Air Jan 19 $43 Puts Sweep (30) at the Ask: 2095 @ $1.65 vs 227 OI; Ref=$44.56

12:21:53 pm: SEE Sealed Air Apr 20 $44 Calls Sweep (39) at the Ask: 1628 @ $3.3 vs 19 OI; Ref=$44.68

11:28:15 am: OSTK Overstock Sep 15 $25 Calls Sweep (39) at the Ask: 1644 @ $0.601 vs 416 OI; Ref=$23.3

Top 10 Bank Stocks To Watch For 2018: Sinovac Biotech Ltd.(SVA)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sinovac Biotech Ltd. (NASDAQ: SVA) is expected to post its quarterly earnings.

    Supercom Ltd (NASDAQ: SPCB) is estimated to post its quarterly earnings at $0.15 per share on revenue of $9.03 million.

Top 10 Bank Stocks To Watch For 2018: Tupperware Brands Corporation(TUP)

Advisors’ Opinion:

  • [By Seth McNew]

    Shares ofTupperware Brands(NYSE:TUP), the classic food-storage brand that has evolved to becomemore than meets the eye, spiked as much as 12% today, after the company reported better-than-expected Q1 earnings and set positive guidance for 2017.

  • [By George Budwell, Rich Smith, and Neha Chamaria]

    Keeping with this theme, our Foolish contributors think that Pfizer (NYSE:PFE),Sherwin-Williams (NYSE:SHW), andTupperware Brands (NYSE:TUP)are three large-cap dividend stocks that prove beyond a doubt that boring is beautiful when it comes to creating wealth.

Top 10 Bank Stocks To Watch For 2018: Callon Petroleum Company(CPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

Top 10 Bank Stocks To Watch For 2018: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Craig Jones]

    JPMorgan’s analyst Michael Gambardella downgraded Century Aluminum Co (NASDAQ: CENX) from Overweight to Neutral and reduced its price target from $22 to $14.50, citing alumina cost headwinds as the main reason for the downgrade.

Top 10 Bank Stocks To Watch For 2018: Female Health Company (The)(FHCO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Female Health Co (NASDAQ: FHCO) were down 15 percent to $1.46 as the company reported that it has entered into a merger agreement with Aspen Park Pharma.

Top 10 Bank Stocks To Watch For 2018: Emerson Electric Company(EMR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected profit for its first quarter on Wednesday.
    Helmerich & Payne, Inc. (NYSE: HP) posted upbeat results for its fourth quarter.
    NetApp Inc. (NASDAQ: NTAP) reported stronger-than-expected results for its second quarter and issued strong Q3 guidance.
    Emerson Electric Co. (NYSE: EMR) proposed to acquire Rockwell Automation (NYSE: ROK) for $225 per share in cash and stock.

  • [By Ben Levisohn]

    Bernstein’s Steven Winoker and team contend that Brexit is “bad for all our companies it is just a matter of degree.” They explain why Tyco International (TYC), Idex (IEX), Danaher (DHR),Honeywell International (HON) and Emerson Electric (EMR) could feel some degree of pain:

  • [By Ben Levisohn]

    3) Other downside catalysts have come and gone, such asEmerson Electric (EMR) effectively ruling out aRockwell deal;

    4) However, our view that the upward trajectory in customer capex spending remains muted combined with the stock still trading at >19x NTM EPS limits our upgrade to just Market-Perform despite our long-term bullish view of industrial automation in general and Rockwell specifically

  • [By Ben Levisohn]

    Shares of General Electric have dropped 3.8% so far this year, with everything from its accounting to weaker margins being blamed for its weakness. Barclays’ Scott Davis and team, however, spoke with a source they call the “smartest man in the room,” who just so happens to be “nibbling” on General Electric now. They explain why and offer his views on Honeywell International (HON), Emerson Electric (EMR), and ITT (ITT) as well:

  • [By Ben Levisohn]

    Lower WACC has moved in lockstep with higher multiples and as the rate regime shifts, we see limited excuses for another leg absent material growth. EPS growth/visibility at a reasonable price will matter, with those that are not reflecting upside today seeing multiple expansion and safety stocks that are not safe reverting. With this backdrop, our top picks are Honeywell, Ingersoll-Rand, and Danaher, with a positive bias on Neutral-rated United Technologies, while we are most negative onGeneral Electric and Rockwell Automation (ROK), with a negative bias on N-rated $51.92 Emerson Electric (EMR)…

Top 10 Bank Stocks To Watch For 2018: Cipher Pharmaceuticals Inc.(CPHR)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Cipher Pharmaceuticals (NASDAQ: CPHR) is said to have hired an investment bank to explore strategic alternatives, according to sources as reported by Reuters on Monday. The sources said a potential sale of the Canada-based company is being considered. Cipher declined comment on the report.

Top 10 Bank Stocks To Watch For 2018: Terra Nitrogen Company L.P.(TNH)

Advisors’ Opinion:

  • [By Robert Rapier] While the MLP space is dominated by the oil and gas sector, in last week’s article we began to explore some of the more exotic master limited partnership offerings. This week we continue our exploration of nontraditional MLPs by looking at the partnerships supplying fertilizer.

    Rentech (Nasdaq: RTK) has been around for more than a decade, and it has shifted strategies several times. Full disclosure: Rentech’s Chief Technology Officer Harold Wright is a former manager of mine when we were both at ConocoPhillips, and I have visited Rentech’s facility in Commerce City, Colorado.

    For most of Rentech’s existence, the company has sought to commercialize alternative fuels. At one time it had ambitions to build a large coal-to-liquids (CTL) plant, but federal legislation ultimately nudged it instead into the biomass-to-liquids (BTL) space. The company did build a BTL demonstration plant, but ultimately shut it down and has now refocused its efforts on becoming “one of the largest wood processing companies in the world.”

    During its interesting journey as a company, Rentech acquired two ammonia nitrogen fertilizer facilities, which turned out to be a profit center that funded the alternative energy research. In November 2011, Rentech spun off this fertilizer business into an MLP called Rentech Nitrogen Partners LP (NYSE: RNF).

    In the months leading to the spin-off, RTK’s market capitalization was about $200 million. Rentech maintained 60 percent ownership of RNF, and three months after the spin-off RTK’s market cap had risen to $400 million, while investors had bid RNF up to $1 billion. Interestingly, RTK’s share of RNF was worth more than RTK’s entire market cap, a situation that persists. The market currently values Rentech at $482 million, while the valuation of Rentech Nitrogen Partners makes RTK’s 60 percent stake in RNF worth slightly more than $600 million — another illu

Top 10 Bank Stocks To Watch For 2018: JA Solar Holdings, Co., Ltd.(JASO)

Advisors’ Opinion:

  • [By Travis Hoium]

    Earnings season is about over for the solar industry, and after JA Solar (NASDAQ:JASO) and Vivint Solar (NYSE:VSLR) reported this week, there were a few major takeaways from the end of 2016 and early 2017.

  • [By Spencer Israel]

    Axiom Capital Managing Director Gordon Johnson upgraded the entire alternative energy sector from Market Underweight to Market Overweight and upgraded SolarCity Corp (NASDAQ: SCTY) from Sell to Hold and Trina Solar Limited (ADR) (NYSE: TSL), Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) from Sell to Buy.

  • [By Lisa Levin]

    Wednesday afternoon, the energy shares surged 1.23 percent. Meanwhile, top gainers in the sector included Frontline Ltd. (NYSE: FRO), up 5 percent, and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO), up 6 percent.

  • [By Wayne Duggan] Related JASO Should You Get Rid of JA Solar (JASO) Now? Earnings Scheduled For May 24, 2017
    Related YGE 18 Biggest Mid-Day Losers For Friday 18 Biggest Mid-Day Gainers For Wednesday

    Solar stock investors may have a surprising new ally in Washington. This week, President Donald Trump suggested that his proposed border wall with Mexico could pay for itself if the wall were covered with solar panels.

Top 10 Bank Stocks To Watch For 2018: Internet Gold Golden Lines Ltd.(IGLD)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, telecommunications services shares fell by 0.43 percent. Meanwhile, top losers in the sector included Internet Gold Golden Lines Ltd (NASDAQ: IGLD), down 10 percent, and China Unicom (Hong Kong) Limited (ADR) (NYSE: CHU), down 3 percent.